1. SPHERE Uptravi® (SelexiPag): tHe usErs dRug rEgistry (SPHERE)

    Submitted by centretek on Sat, 10/15/2022 - 10:29
    Summary
    To develop and maintain a database of de-identified patient medical information and other related information in order to better assess and optimize outcomes for patients diagnosed with PAH and receiving treatment with Uptravi®. Age Group: Patients ≥ 18 years of age at time of Uptravi initiation. National Clinical Trial (NCT) identifier on clinicaltrials.gov: NCT03278002

  2. SPOCK: Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor after Aromatase Inhibitor and CDK inhibition. A Phase II, open label, interventional trial using gene expression based biomarkers of estrogen activation in advanced

    Submitted by centretek on Sat, 10/15/2022 - 10:29

  10. The Targeted Agent and Profiling Utilization Registry (TAPUR) Study

    Submitted by centretek on Sat, 10/15/2022 - 10:29
    Summary
    The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial that aims to describe the performance (both safety and efficacy) of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer that has a potentially actionable genomic variant. The study provides approved targeted therapies that are contributed to the program by collaborating pharmaceutical companies, catalogues the choice of genomic profiling test by clinical oncologists and aims to learn about the utility of registry data to develop hypotheses for additional clinical trials.
Subscribe to